Blackstone Strategic Credit Fund
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BGB research report →
Price Chart
About the company
Blackstone Strategic Credit 2027 Term Fund is a close ended fixed income mutual fund launched and managed by GSO / Blackstone Debt Funds Management LLC. It invests in the fixed income markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors.
- CEO
- Daniel Harlan Smith
- IPO
- 2012
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on BGB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $494.43M
- P/E
- 1106.00
- PEG
- -11.17
- P/S
- 8.12
- P/B
- 0.94
- EV/EBITDA
- 45.22
- Div Yield
- 8.37%
- Gross Margin
- 83.23%
- Op Margin
- 29.62%
- Net Margin
- 0.54%
- ROE
- 0.06%
- ROIC
- 1.99%
Latest fiscal year · YoY change
- Revenue
- $65.80M-25.6%
- Gross Profit
- $55.43M-28.7%
- Op Income
- $49.00M
- Net Income
- $30.08M-46.1%
- EPS
- $0.67-46.4%
- OCF Growth
- -118.7%
- FCF Growth
- -118.7%
- 52W High
- $12.01
- 52W Low
- $10.85
- 50D MA
- $11.21
- 200D MA
- $11.37
- Beta
- 0.41
- RSI (14)
- 43
- Avg Volume
- 162.46K
No earnings-call transcripts are available for BGB yet.
- Free Float
- 100.0%
- Shares Outstanding
- 44.66M
- Float Shares
- 44.66M
of shares held by institutions
86 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Sit Investment Associates Inc | 3.64M | ▲ 882.29K |
| Morgan Stanley | 2.54M | ▲ 312.29K |
| Coastal Bridge Advisors, LLC | 2.26M | ▼ 192.48K |
| Wells Fargo & Company/Mn | 1.76M | ▼ 106.79K |
| Bank Of America Corp | 1.66M | ▼ 316.51K |
| Raymond James Financial Inc | 1.14M | ▼ 14.42K |
| Atlas Wealth LLC | 939.96K | ▲ 939.96K |
| Hightower Advisors, LLC | 934.51K | ▲ 23.47K |
| Cresset Asset Management, LLC | 722.56K | ▲ 44.38K |
| Advisors Asset Management, Inc. | 591.68K | ▼ 248.34K |
| Ubs Group AG | 502.17K | ▲ 9.22K |
| Loomis Sayles & Co L P | 497.86K | ▲ 68.34K |
Held by 15 ETFs
Biggest fund positions in BGB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 28, 26 | Leeson Patricia Anne | other | 0 |
| Nov 15, 24 | Leiter Daniel | other | 0 |
| Nov 15, 24 | McMullen Daniel T | other | 0 |
| Nov 15, 24 | Michel Kevin David | other | 0 |
| Nov 15, 24 | Fornshell Meghan | other | 0 |
| Oct 31, 23 | McKemie Gordon | buy | 4,760 |
| Sep 28, 23 | Naratil Valerie | buy | 120 |
| Jul 25, 23 | MetLife Investment Management, LLC | other | 0 |
| Jun 26, 23 | McKemie Gordon | buy | 11,500 |
| Jun 22, 23 | McKemie Gordon | buy | 18,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BGB coverage
Recent articles, reports, and earnings notes.
No research on BGB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BGB report →Triple-Factor Closed-End Fund Report, September 2026: HFRO's Discount Keeps Widening
seekingalpha.com · Sep 25
BGB: Discount Widens On Term Fund With Institutional CEF Investor Taking A Stake
seekingalpha.com · Apr 8
Income-Covered Closed-End Fund Report, March 2026
seekingalpha.com · Apr 1
CEF Market Weekly Review: Aberdeen Proposes Removing Fund Term Structure
seekingalpha.com · Mar 28
The Chemist's Triple-Factor Closed-End Fund Report, October 2025
seekingalpha.com · Oct 25
BGB: Discount Worth Watching With Term Approaching
seekingalpha.com · Oct 16
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom's Macroglobulinemia
businesswire.com · Jul 31
BGB's Biggest Risk Is A Pivot In Rate Policy
seekingalpha.com · Jul 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.